Heme-CO binding to tryptophan-containing calmodulin mutants  by L'Hostis, Estelle Leclerc et al.
ELSEVIER Biochimica et Biophysica Acta 1313 (1996) 209-216 
BB 
Biochi ~mic~a et Biophysica A~ta 
Heme-CO binding to tryptophan-containing calmodulin mutants 
Estelle Leclerc L'Hostis a,1, Liliane Leclerc a, Jacques Haiech b, Claude Poyart a, 
Michael C. Marden a,* 
a lnstitut National de la Sant~ et de la Recherche M£dicale, Unit~ 299, HOpital de Bic~tre, 94275 Le Kremlin-Bic~tre, France 
b LCB, CNRS, 13277 Marseille, France 
Received 12 June 1996; accepted 19 June 1996 
Abstract 
The binding of heme-CO to genetically engineered caimodulin containing a single tryptophan residue has been studied. A tryptophan 
residue was integrated at one of five positions: 26 or 62 of the N-terminal, 81 in the central helix, or 99 or 135 of the C-terminal. As for 
the wild type, the mutant calmodulins bind four molecules of heme-CO with an average affinity of 1 IzM. (i) Homotropic effect. The 
quenching of the tryptophan fluorescence by energy transfer to the heroes indicates that there is no preference between the N- or 
C-terminal pockets for heme binding. The quenching is less than expected for a binomial distribution of four sites. This could indicate a 
lower energy transfer rate due to a specific orientation factor. The weak quenching as a function of the number of hemes bound may also 
reveal a cooperativity in the heme binding; the data can be simulated assuming two pairs of sites, where each pocket shows a cooperative 
binding for two hemes. (ii) Heterotropic effect. As observed for the wild type, addition of melittin does not displace the hemes from the 
mutant calmodulins; the affinity of heme-CO for the calmodulin •melittin complex is higher than that for calmodulin alone. The affinity 
of heme-CO for native calmodulin is also higher in the presence of trifluoperazine. 
Keywords: Calmodulin; Heme; Fluorescence energy transfer; Trifluoperazine; Synergy 
I. Introduction 
Calmodulin belongs to the family of calcium-binding 
proteins, a family that is growing larger every year, con- 
sisting of more than 150 proteins [1]. Binding of four 
calcium ions induces a conformational change in calmod- 
ulin which can then activate a large number of proteins. 
These target proteins are implicated in vital cellular func- 
tions such as the homeostasis of calcium, energy 
metabolism, cell division, AMPc metabolism, the release 
of synaptic vesicles or the contraction of striated or smooth 
muscular cells [2]. The crystallographic structure of 
calmodulin shows the presence of two hydrophobic pock- 
ets located symmetrically, relative to the central helix (Fig. 
1), in the N- and C-terminal domains of the protein [3]. 
These two pockets are involved in the interaction of 
calmodulin with its targets. 
The crystallographic structure of calmodulin in the pres- 
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ence of the calmodulin-binding domain of the smooth 
muscular Myosin Light Chain Kinase has been determined 
recently [4], as well as that with the binding domain of 
calmodulin-dependent protein kinase II [5]. A high degree 
of flexibility must be considered for CaM, since in the 
presence of its target protein domain, the central helix of 
calmodulin is bent, allowing a hydrophobic interaction 
between the pockets and residues of the calmodulin-bind- 
ing domain. These hydrophobic pockets are also impli- 
cated in the binding of the phenothiazine-related drugs to 
calmodulin, as first suggested by the effects of the drugs 
on the absorbance and NMR properties [6,7] and more 
directly by determining the crystallographic structure for 
the trifluoperazine • calmodulin complex [8,9]. 
We have shown previously that calmodulin can bind up 
to four molecules of heme-CO with micromolar affinity 
[10]. As opposed to other hydrophobic probes, heme-CO 
can be used with both absorbance spectroscopy and fluo- 
rescence quenching studies. The goal of this work is to 
characterize the binding sites of heme-CO by the energy 
transfer method between calmodulin and the heme-CO 
molecules. The fluorescence nergy transfer between the 
tryptophan and the heme can help localize the heine 
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Fig. 1. Structure of calcium-bound calmodulin [3] showing the positions 
where tryptophan residues were substituted (Molscript graphics, [43]). 
binding sites. By measuring the fluorescence quenching as 
a function of the number of bound hemes, one can study 
the homotropic effect, that is whether the heme-CO bind- 
ing is cooperative. Since the binding of four molecules of 
trifluoperazine has been reported, we also studied this 
heterotropic effect: whether trifluoperazine acts as a com- 
petitor with heine-CO for the calmodulin sites. The present 
results indicate that trifluoperazine induces an increase in 
the affinity of calmodulin for heme-CO, revealing a syner- 
gic effect between heme-CO and trifluoperazine binding to 
calmodulin. 
For the present experiments, we have used five calmod- 
ulin mutants containing a single tryptophan residue. Native 
calmodulin has no tryptophan residues, resulting in only a 
weak absorbance or fluorescence signals from the two 
tyrosines [11]. By genetic engineering methods Kilhoffer et 
al. [12] have produced isofunctional calmodulins in which 
a single tryptophan has been introduced into one of the 
calcium binding loops or in the middle of the central helix 
of the protein. 
The energy transfer between tryptophan and heme is 
responsible for the very low quantum yield of tryptophan 
residues in hemoglobin t / )Hb/ / (~ ap°Hb = 0.03 [13,14]. The 
fluorescence yield can thus serve as a sensitive test for 
heine loss or protein denaturation i  hemoproteins [15]. 
For the calmodulin •heme complex, studies of the energy 
transfer between the tryptophans and heroes provide a 
better description of the heme pockets within calmodulin. 
2. Materials and methods 
ously [16,17]. The protein concentration was determined 
from the absorption band at 276 nm with E = 3740 M-  
cm -l  [18]. 
2.2. Production of  calmodulin mutants 
The five tryptophan-containing calmodulin mutants 
studied were T26W, T62W, F99W, Q135W and S81W. 
Four of the mutations were designed with one tryptophan 
in an equivalent position in each of the calcium-binding 
loops of the protein; the fifth mutation is localized in the 
middle of the flexible central helix of calmodulin (Fig. 1). 
These mutations were produced by genetic engineering 
from the SYNCAM; protein production was with the 
VUCH-1 vector [19] using cassette mutagenesis as previ- 
ously described [ 12,20,21 ]. The constructs were controlled 
by verifying the DNA sequence as described previously 
[22], by analysing the amino-acid composition and in 
selected cases, by automated amino-acid sequence analysis 
of the purified protein [23]. Fermentation and large-scale 
production of each protein was done at the CNRS Fermen- 
tation Center in Marseille, France [24]. While native CaM 
has tyrosines at position 99 and 138, the starting point for 
the mutants was the sequence VU1 which has a phenyl- 
alanine at position 99 (e280 = 1500 M -1 cm-1). In the 
presence of calcium, the absorption coefficients at 280 nm 
are e= 6150 M -~ cm -j for the mutants T26W, S81W, 
and Q135W, and e= 7400 M -1 cm -l  for the mutants 
T62W and F99W. 
2.3. Preparation of  heme-CO 
Heroin (Sigma) was dissolved in 0.1 M NaOH and 
subsequently diluted in 50 mM Tris-HC1 buffer at pH 7.4. 
Fresh solutions were used to avoid aggregation of the 
hemes. Heme-CO was prepared by reduction of hemin 
with an anaerobic buffered solution of sodium dithionite, 
equilibrated under 1 atm CO; the heme-CO concentration 
was calculated from the Soret (407 nm) absorption with 
E= 147000 M -1 cm - l  [25]. 
2.4. Fluorescence measurements 
The fluorescence spectra of calmodulin were measured 
on an SLM-Aminco 8000 spectrofluorimeter. The excita- 
tion wavelength was set at 295 nm for selective xcitation 
of tryptophan residues. Samples were in quartz cuvettes 
(4 × 10 mm) with excitation along the 4 mm axis. Each 
spectrum was corrected by subtraction of the spectrum of 
the buffer alone in the same conditions. 
2.1. Preparation of  native calmodulin 
Calmodulin was prepared from bovine brain acetone 
powder (Sigma) according to methods described previ- 
2.4.1. Energy transfer 
The binding of heme-CO to calmodulin can be followed 
by the decrease of the fluorescence yield @ of the trypto- 
phan within the mutant. FiSrster's theory [26] relates the 
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efficiency of energy transfer E---q~/@0 to the donor- 
acceptor separation R as: 
e = e 0 [( 1 - E)/ /El  1/6 (1) 
R 6 = 8.78.10 -25. K 2. qb 0-n -4 - J  (2) 
R 0 (in cm), the critical distance for 50% energy trans- 
fer, is given in Eq. (2), where /(,2 is the orientation factor, 
taken as 2 /3  which represents an average value over all 
possible orientations between the donor and the acceptor 
[27]. q>0 is the quantum yield of the donor in the absence 
of acceptor. The index of refraction n was taken equal to 
1.335 for an aqueous medium. J is the spectral overlap 
integral defined by: 
J= f r (v ) ,  e (v ) .  v -4 dv,/fF(~,)dv (3) 
where F(~,) is the fluorescence intensity of the energy 
donor, E(P) is the molar extinction coefficient of the 
energy acceptor (M-1 cm-l ) ,  and v is the frequency in 
cm -1. Typical values of R 0 for energy transfer from 
o 
tryptophan to heme are about 35 A, which leads to a weak 
fluorescence for proteins maller than a typical hemoglobin 
subunit (17 kDa). 
2.4.2. Inner filter effect 
The efficiency of the energy transfer between the tryp- 
tophan and the molecules of heme-CO was determined by 
first measuring the emission intensity of the calcium bound 
calmodulin (which binds heine-CO) and then after addition 
of EDTA, to chelate the calcium atoms, which frees the 
heme-CO molecules. By this method, we could eliminate 
the problem of the inner filter effect due to the absorbance 
of the sodium dithionite and the hemes. An alternative 
method is to correct for the inner filter effect; measure- 
ments were made of the fluorescence of free DL-tryptophan 
(Sigma) at the same heme-CO concentrations; typical de- 
creases in the peak fluorescence intensity were 20% at 10 
/zM heme-CO. The correction is thus important, although 
small compared to the changes due to energy transfer. 
Since the inner filter effect distorts the shape of the 
emission spectrum, we used the peak intensity to estimate 
the yield. 
2.5. Basis of the heme-CO binding models 
The overall fluorescence intensity is the sum of the 
partially liganded species. There will be model-dependent 
statistical factors, depending on the cooperativity of heme 
binding, and for each species a reduced fluorescence yield 
depending on the tryptophan-heme distances. We assume 
that the four bound molecules of heme-CO are localized in 
the two hydrophobic pockets of calmodulin, with at most 
two molecules of bound heme-CO in each pocket. We 
therefore consider partially liganded populations of 
calmodulin (Pi) where i can vary from 0 to 4. 
Fobs = D0 " P0 + ~1 ' P l  "-I- ql~ 2 • P2 q- qb3 " P3 "k- qb 4 • P4 
(4) 
Since we are interested in the relative yield, we normal- 
ize the amplitudes with q~0 = 1. The quenching factor will 
depend on whether the heme is in the same (N- or C-termi- 
nal) domain as the tryptophan. We assume by symmetry 
that there are equal populations of the (N- or C-domain) 
pockets. When one molecule of heme-CO is bound in the 
same domain as that of the tryptophan, the distance is 
small enough to suppose that the emission intensity of 
fluorescence is null (Table 1). For a molecule of heme-CO 
bound in the pocket opposite that of the tryptophan, we use 
FiSrster's theory to estimate the quenching factor, which is 
about a factor of 2 (Table 1) in this case where the 
distance R is about 35 A. 
In general, one can treat either the amplitudes or the 
populations as parameters. Three models are described, 
which differ in the cooperativity of the heme binding to 
two identical calmodulin pockets. We suppose that the four 
binding sites are: (1) independent and identical, in which 
case the populations of partially liganded forms can be 
obtained from the binomial distribution, or (2) cooperative 
two by two (where the heroes bind as cooperative pairs) 
and (3) a highly cooperative binding of four hemes result- 
ing only in forms with 0 or 4 hemes bound. For the first 
case of a random distribution, we also consider the effect 
of varying the fluorescence yield ~.  
2.5.1. Case of four independent and equivalent binding 
sites 
For the model with four independent sites, the popula- 
tions Pi of species with i = 4, 3, 2, 1, 0 ligands would be 
given by the binomial distribution as f4 ,  4f3(1 _ f ) ,  
Table 1 
Tryptophan-heme pocket distances for mutant calmodulins 
CaM Ro(,~) R(A) F / F o R(,~) F / F o 
W¢~ F19 WoF92 
T26W 40 9 0 42 0.6 
8 0 23 0.03 
T62W 35 13 0.003 40 0.7 
9 0 26 0.07 
SSIW 39 21 0.02 15 0.003 
23 0.04 18 0.01 
F99W 37 38 0.5 11 0 
25 0.09 9 0 
Q135W 35 40 0.7 14 0.004 
27 0.17 13 0.003 
The distances R were estimated between the tryptophan and the hy- 
drophobic pockets (N- and C-domain), using the crystallographic struc- 
ture of either the calcium bound form (upper line; the structure of Babu et 
al. [3]), or in the compact form determined in the presence of calcium and 
the peptide M13 (lower entry; [4]). We determined the distances W-F19 
and W-F92 to represent he distances to the pocket in the N- and 
C-domain, respectively. The distance for 50% quenching (R 0) was 
calculated from the energy transfer theory (Eqs. (2) and (3)), using the 
quantum yield of the mutant CaM [24]. 
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6f2(1 _ f )2 ,  4f(1 _f )3,  and (1 __f)4, respectively, where 
f is the fraction of sites occupied. Thus at 50% saturation 
( f=  0.5 or two hemes per CAM), there would be about 6, 
25, 37, 25, and 6% of these forms. In addition, we 
distinguish eme binding to the N- or C-terminal calmod- 
ulin pockets. Thus, for the four possible subspecies with 
one ligand, there are two of each type: only the forms with 
the heme in the domain opposite to the tryptophan will 
make a significant contribution (q~lO) to the fluorescence. 
Similarly, for the six doubly liganded substates, there is 
only one form (where both hemes are in the pocket 
opposite to the tryptophan) which can make a substantial 
contribution (qb2o) to the overall fluorescence intensity: 
Fobs --= ~0" (1 _ f )4  + qDlo " 2 f ( l  _ f )3  
+ qb2o .f2(1 _ f )2  (5) 
The forms with three or four hemes bound will neces- 
sarily have at least one heine in the same domain as the 
tryptophan and will therefore be highly quenched. In sum- 
mary, for the case of random heine-CO binding, the indi- 
vidual populations are determined from the binomial distri- 
bution, and the fluorescence yields (q0) can be estimated 
from the energy transfer formula, but in general can be 
treated as parameters. 
2.5.2. Case where the hemes bind cooperatively (two by 
two) in each CaM pocket 
For highly cooperative pairs, there are three populations 
of liganded calmodulin: the forms with zero, two, or four 
molecules of bound heme-CO. When two molecules of 
heme-CO bind to calmodulin, they bind as a dimer to 
either the N- or C-terminal pocket. Assuming identical 
pockets, the binomial distribution is used to calculate the 
fraction of the forms with 4, 2, or 0 hemes bound: f2, 
2f(1 - f ) ,  (1 _f)2.  Considering again that the hemes may 
bind in either the same or the opposite protein domain, 
there are four distinct species, of which only two fluoresce: 
Fobs = qb ° .f2 + qb2o "f(1 -- f) .  
2.5.3. Case of four cooperative binding sites 
In the case of a highly cooperative system, there are 
only two populations: (1 - f )  for calmodulin with zero, or 
( f )  for four molecules of bound heme-CO. The observed 
fluorescence is only due to the unliganded form: Fob s = @o 
• (1 - f ) .  
3. Results 
3.1. Absorption 
As for the native CaM [10], the mutants bind four 
molecules of heme-CO with an average affinity of 1 /zM. 
The absorption spectra for the bound hemes are shown in 
Fig. 2. Considering the various mutants, there is no differ- 
ence in the position of the Soret absorption band (419 nm) 
and little variation (20%) in the amplitude of this peak. In 
all cases, the hemes remain bound after addition of melit- 
tin, but there is a release of the hemes after addition of 
EDTA (to chelate the calcium) or ethylene glycol (50%, 
v/v).  As for native CaM, the binding of heine-CO to 
mutant CaM is thus calcium dependent, and appears to be 
hydrophobic in nature. 
Scatchard plots for the binding of the four hemes were 
usually not conclusive. Since the absorbance is due to the 
ligand (heme), very low concentrations lead to poor sig- 
nals. Concentrations of heme-CO above 50 /zM can pre- 
sent problems of dimerization, or secondary binding sites 
of much lower affinity. 
Our usual method to determine the stoichiometry of the 
binding is to prepare different ratios of CaM to heme-CO 
at concentrations well above the binding affinity (for ex- 
ample 20/zM heme-CO and 1, 2, 4, 5, and 10/xM CAM). 
By treating the intermediate absorption spectra s a sum of 
free and bound heme-CO, we determine that four molecules 
of heme-CO can bind. 
As observed with native calmodulin, addition of melit- 
tin does not displace the heroes. It seems to act as a cap, 
since the affinity of heme-CO for this complex is an order 
of magnitude higher [28]. 
3.1.1. Competition with trifluoperazine 
Since CaM has also been reported to bind four molecules 
of trifluoperazine, it was natural to ask whether they may 
be the same sites as for heme-CO. As a first step we 
looked for an interaction between these two hydrophobic 
molecules; addition of trifluoperazine to a solution of 
heme-CO can shift the heme Soret band from 407 to 422 
nm, with a large loss in absorbance. For a fixed heme 
concentration of 10 /zM, the midpoint of the transition to 
the absorption peak at 422 nm occurs near 100 /zM 
trifluoperazine; subsequent addition of CaM shifts the 
1.4- 
1.2 
1- 
g - 
~ 0.8 
< 0.6 
0.4- 
0.2" 
" Heme-CO 
°31~o 460 420 440 
Wavelength (nm) 
Fig. 2. Absorption spectra of heme-CO and heme-CO bound to the 
calmodulin mutant T26W. Experimental conditions: Tris-HCl buffer at 
pH 7.4, 5 /zM CaM, 20 /zM heme-CO, 1mM CaCI:. 
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Fig. 3. Absorption spectra of the calmodulin, heme-CO complex in the 
absence and presence of 10/xM trifluoperazine. Experimental conditions: 
0.4 /xM CaM and heme-CO in Tris-HC1 buffer (pH 7.4), 1 mM CaCI:. 
Soret band to 419 nm, typical of the CaM. heme-CO 
complex. Addition of EDTA to this solution frees the 
heme-CO from CaM and the spectrum for the heme-CO • 
trifluoperazine complex is again observed. If heme-CO and 
trifluoperazine compete for the same sites on CaM, one 
would expect a lower apparent affinity of heme-CO for 
CaM in the presence of trifluoperazine. Yet the opposite 
was observed (Fig. 3); at 20 /xM trifluoperazine (below its 
affinity for a direct interaction with heine-CO) an increase 
in affinity (about 5-fold) of heme-CO for CaM was deter- 
mined. These results suggest a synergic binding of the two 
ligands to CaM. 
3.2. Fluorescence quenching 
The quenching of the tryptophan fluorescence by en- 
ergy transfer to the hemes was less than expected (Fig. 4). 
For the mutants with a tryptophan in either the N- or 
C-terminal domain, a factor of quenching of only 1.5 was 
observed for samples with one heme per CaM. Mutant 
W81 showed a higher quenching (factor of 2) at one heme 
per protein (Fig. 5). Note that hemoproteins such as myo- 
globin or the isolated chains of hemoglobin typically show 
at least a factor of 20 quenching of the tr~ptophan fluores- 
cence. Calculations indicate R 0 = 35 A (Table 1), so 
quenching of factors of 2, 10, 50 would be expected for 
o 
distances of 35, 30, and 20 A, respectively. 
If one considers the crystallographic structure of cal- 
cium-bound calmodulin [3], the protein of overall ength of 
65 ,~ has two globular domains eparated by a long central 
helix. Thetwo hydrophobic pockets would be separated by 
about 35 A. The weak quenching could be explained if the 
hemes had an equal probability of binding to the two 
pockets. One would then expect a strong quenching (greater 
than a factor of 100) when the heme is in the same half as 
the tryptophan, but a moderate quenching of about a factor 
of 2, when the heme anti the tryptophan are in opposite 
100, 
8O 
O 
t-- 
60 
= 40 
20 
0 i 2 3 4 
Homes bound per CaM 
Fig. 4. Fluorescence quenching by heme-CO of the mutant calmodulin 
T26W (•). Simulations were made using a random (binomial) distribu- 
tion of the four heine-CO binding sites, with variation of the fluorescence 
quenching factor (Eqs. (4) and (5)): ~t = 0.015 (curve a, for the compact 
CaM.peptide structure, see Table 1); 0.3 (b) for the CaM.Ca structure, 
and 0.4 (c) assuming no quenching for one of the hemes. The fraction 
fluorescence is the observed emission peak intensity in the presence of 
calcium, relative to samples with EDTA. Conditions: Tris-HC1 buffer at 
pH 7.4, 5 /xM CaM, 1 mM CaCI2, excitation at 295 nm. 
pockets. For the centrally located mutant W81, the quench- 
ing should be strong for heine binding to either pocket. 
Considering the five mutants (Figs. 5 and 6), the quench- 
ing data at one heme per CaM indicate that there is no 
preference of heme binding for the N- or C-terminal 
pockets. 
3.2.1. Simulation of fluorescence quenching data 
The quenching is weak, relative to the high quenching 
factors for hemoglobin or myoglobin. At two heroes per 
CaM, the quenching is only a factor of 4 for all the 
mutants except W81 (factor of 5). A random distribution 
(model 1) of hemes predicts an overall quenching of over a 
factor of 6 at two hemes per CaM (Fig. 4), corresponding 
to 6% of the proteins without any hemes (and therefore 
100  
o erative 4 
t- 
O 
20 bi 
0 i 2 3 4 
Homes bound per CaM 
Fig. 5, Fluorescence quenching by heine-CO of mutant CaM S81W. 
Conditions as for Fig. 4. The simulations are for models involving 
different cooperativity: a random distribution of four ligands, 'coop 2 X 2' 
for the binding of cooperative pairs in each domain, and cooperativity of 
all four hemes. 
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Fig. 6. Fluorescence quenching by heme-CO of mutant CaM with a single 
tryptophan located in the calcium binding loop: ([]) T26W; (×) T62W; 
( I )  F99W, (A) Q135W. Conditions as given for Fig. 4. The models 
indicated are as shown in Fig. 5. 
unquenched), and an additional 25% with one heme of 
which half are in the pocket opposite the tryptophan (and 
therefore quenched by about a factor of two). 
3.2.1.1. Energy transfer efficiency. One explanation of the 
weak quenching could be a smaller quenching factor than 
estimated from the F/Srster theory. A specific orientation of 
the tryptophan dipole perpendicular to the heme plane 
could result in such a weak transfer. 
Note that a different conformation of calmodulin would 
also change the quenching factors. Considering the com- 
pact form of calmodulin, observed in the presence of target 
peptides, the inter-domain distance would be smaller lead- 
ing to a lower • (Table 1). In Fig. 4 we present simula- 
tions for different values of qb~ = 0.015 (for the compact 
CAM), 0.3 for the elongated structure (60% fluorescence 
for two of the four possible heme positions). An additional 
simulation is shown with a value of 0.4, assuming no 
quenching for one heme position (in the opposite domain) 
and 40% for the other, still with full quenching for a heme 
located in the same domain as the tryptophan; note that 
this last case approaches the observed quenching curve, 
but requires a specific and rigid heme-tryptophan orienta- 
tion. 
3.2.1.2. Difference in population. Another explanation for 
the weak quenching would be a cooperative binding for 
the hemes. When ligands bind cooperatively, such as the 
four oxygens to Hb, there is a decrease in the populations 
of the partially liganded forms. Thus rather than changing 
the fluorescence yields, cooperativity would change these 
populations. For a highly cooperative system, there is a 
tendency to flip from the form with 0 to 4 ligands, a more 
efficient way of loading and unloading the ligands. For the 
case of high cooperativity of four ligands, there would be a 
fraction f of the form with four ligands, where f is the 
fraction of all sites that are bound. At 50% saturation 
( f=  0.5 or 2 ligands per protein) one would expect only a 
factor of two quenching (Fig. 5). 
The results of fluorescence quenching versus the aver- 
age number of hemes bound are shown in Figs. 4-6. The 
data are intermediate to the extreme cases of a random 
distribution and a cooperative system. 
4.  D iscuss ion  
Since the data at one heme per CaM are independent of
the position of the tryptophan probe, we assume that the 
two pockets have a similar affinity for the hemes. Since 
the quenching is less than expected for a random distribu- 
tion, we tried two methods to treat he data: a lower energy 
transfer ate, or a non-random distribution. 
4.1. Statistical versus energy transfer parameters 
Variations in the donor-acceptor distances or orientation 
will affect the quenching factor for a given partially lig- 
anded species; variation of the fluorescence yields of the 
partially liganded forms (@i) can simulate the data if one 
assumes no quenching for at least one heme (Fig. 4). This 
would require a specific and static geometry of heme 
binding; this condition would not be fulfilled for a flexible 
central helix, which would average the orientation factor in 
a dynamical fashion. In addition it would seem improbable 
that all the CaM mutants would satisfy this stringent 
condition. 
The statistical factors also play an important role (Figs. 
5 and 6). The difference in cooperativity of ligand binding 
changes the populations of the partially liganded species. 
Cooperativity decreases the amount of partially liganded 
forms, and therefore nhances the fraction with no hemes 
bound - the species which makes the dominant contribu- 
tion to the overall fluorescence intensity. The simulations 
are more sensitive to changes which effect the amount of 
unliganded CaM (rather than errors in the F~Srster parame- 
ters) which depends on the cooperativity of ligand binding. 
4.2. Heme CO molecules in the hydrophobic pocket of  
calmodulin 
Heme is composed of a central iron atom within a 
protoporphyrin-lX ring, which confers a planar geometry 
to the molecule. Two side chains of this ring possess one 
negative charge due to carboxylic group of propionate 
residues. The heme can be considered as amphiphilic, 
consisting of a hydrophobic core and two charged 
sidechains. With its hydrophobic properties, the heme 
group can easily find a place in the hydrophobic pocket of 
calmodulin (Table 2). 
It was envisaged that the iron of the protoporphyrin 
could form a 6th coordination bond with the lateral chain 
of a histidine in calmodulin, as is the case in myoglobin or 
hemoglobin [29,30]. However, there is only one histidine 
(His-107) in the calmodulin sequence and the protein binds 
up to four molecules of heme-CO. If the heme were to 
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Table 2 
Hydrophobic residues of the calmodulin pockets [3l 
N-terminal pocket: C-terminal pocket: 
Phe- 19 Phe-92 
Ile-27 Ile- 100 
Leu-32 Leu-105 
Val-35 Val-108 
Met-36 Met- 109 
Pro-43 Leu-116 
Leu-48 Val- 121 
Met-51 Met- 124 
I1e-52 lie- 125 
Val-55 Ala- 128 
I1e-63 Val- 136 
Phe-68 Phe- 141 
Met-71 Met-144 
Met-72 Met-145 
The underlined residues make contact with one trifluoperazine molecule 
(TFP1 and TFP4; [9]). 
bind preferentially to this histidine, there should be a 
difference in the energy transfer esults for the various 
mutants of calmodulin. But these experiments show no 
preference between the N- and C-terminal pockets for the 
heme binding. 
Among all the residues usceptible to form a coordina- 
tion with the heme iron, the most probable could be the 
lysine residues. Indeed seven of the eight lysines of 
calmodulin possess a free lateral chain. The 8th is the 
trimethyllysine-115 in native CaM (which is not trymeth- 
ylated in the mutants). Chemical labelling experiments 
have shown that two of these lysines are particularly 
reactive [31-33]: lysine-75, whose lateral chain points out 
to the N-terminal hydrophobic pocket, and lysine-148, 
which is by symmetry the counterpart of lysine-75. Lysine- 
75 is 25-times more reactive to acylation in the presence of 
calcium, in agreement with the fact that its lateral chain is 
more exposed in the presence of calcium [34]. Moreover, 
the acylation of these two lysines prevents the binding of 
trifluoperazine, which binds in the hydrophobic pockets of 
calmodulin [35]. 
One possibility for the cooperative heme binding is that 
the first heme to bind could form a coordination with one 
of the lysines and the second heme could stack on the first 
to form a dimer, thus explaining the cooperativity of the 
hemes binding. We have shown previously for the calmod- 
ulin • heme-CO complex, the photodissociated CO rebinds 
to the iron with a high proportion of geminate phase [28]. 
This indicates a full pocket around the heme which pre- 
vents an easy escape of the ligand; for heme dimers, the 
rapid kinetics could involve an exchange of CO between 
the hemes. 
4.3. Heterotropic effects 
There is a discrepancy in the ways of interaction of 
different drugs to calmodulin. For example, Massom et al. 
[36] have shown that four molecules of trifluoperazine 
bind to calmodulin (K d ---5.8 /zM) in four independent 
binding sites. In this case, the binding of one melittin 
displaces two molecules of trifluoperazine. Other authors 
[37,38] have reported that two molecules of felodipine, a
dihydropyridine Ca 2÷ antagonist, bind to calmodulin (K d 
= 22 /zM) in a cooperative way; addition of either preny- 
lamine or R24571 to the CaM • felodipine complex induces 
the loss of one molecule of felodipine, while increasing the 
affinity (Ko=0.5  ~M) of the remaining felodipine 
molecule. These authors concluded that the binding of 
prenylamine or R24571 to a single site on calmodulin 
results in an allosteric transition, enhancing the affinity of 
felodipine at a second binding site. Similarly, Newton et 
al. [39] observed an increased rate of incorporation of their 
affinity label 2-chloro-10-(3-isothiocyanatopropyl)pheno- 
thiazine when trifiuoperazine was added at low concentra- 
tion. 
In this study we have shown that the binding of heme- 
CO to calmodulin does not follow the model of four 
independent sites. The cooperativity within each pocket 
(Case 2) for the binding sites suggests that the two do- 
mains of the protein bind ligands independently. More- 
over, we have already shown that binding of melittin to the 
calmodulin. (heme-CO) 4 complex does not result in the 
release of any heme-CO [28]. Thus melittin could be 
considered as a potentiator to the binding of the heine-CO 
molecules. There is no crystallographic structure of the 
CaM. melittin complex; however, different NMR results 
indicate that both the N and C domains of CaM are 
involved in the interaction with melittin [40,41]. Small 
angle X-ray scattering experiments in solution have sug- 
gested a more compact structure for the complex, as 
determined crystallographically with peptide M13 of the 
smooth muscle myosin light chain kinase [42]. Since melit- 
tin will help shift CaM to a new 'activated' structure, it is 
reasonable that the affinity of heme-CO to the CaM pock- 
ets may be increased; there may also be direct interactions 
between the bound heme-CO and this amphiphilic peptide. 
We have also shown a synergic effect occurs for the 
binding of heme-CO and the drug trifluoperazine to 
calmodulin. Our results show that there in an enhanced 
binding of heme-CO to CaM in the presence of trifluopera- 
zine. Since heme is not released when trifluoperazine is 
added to the complex, we assume the presence of all three 
components in the complex. This suggests that trifluopera- 
zine may induce a conformational change in calmodulin 
which facilitates the binding of heme-CO. The binding 
sites for the two ligands may be cooperative, with calmod- 
ulin adopting the same globular structure as observed with 
target peptides. In this complex, the hydrophobic part of 
the trifluoperazine molecule could interact with hydropho- 
bic residues of CaM or with the macrocycle of heme. 
Moreover, in this case the piperazine group of trifluopera- 
zine could neutralize the negative charges of the propi- 
onate groups of the hemes. The crystallographic structures 
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of calmodulin complexed with a target domain [4,5] or 
with trifluoperazine [8,9] all show a compact form of 
calmodulin. One must therefore consider at least three 
structures for calmodulin: with and without calcium, and 
the compact form in the presence of targets. In addition to 
these 'average' structure the flexibility and dynamical 
aspects are clearly implicated for the interaction of 
calmodulin with its targets. 
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